Factors associated with long-term use of FDA-approved anti-obesity medicationsOnly 19% of the patients continued to use the anti-obesity medications (AOMs) one year after their initial prescriptions and patients...
Bariatric patients have lower pregnancy weight gain vs non-surgical controlsWomen with a history of bariatric surgery had lower pregnancy weight gain than matched controls with similar early-pregnancy...
Bariatric patients have lower pregnancy weight gain vs non-surgical controlsWomen with a history of bariatric surgery had lower pregnancy weight gain than matched controls with similar early-pregnancy...
Factors associated with long-term use of FDA-approved anti-obesity medicationsOnly 19% of the patients continued to use the anti-obesity medications (AOMs) one year after their initial prescriptions and patients...
Zepbound (tirzepatide) available in US pharmacies for adults living with obesityEli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...
Journal Watch 6/12/2023Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Comprehensive preoperative evaluations and individualised treatment plans reduced post-surgical ICU Researchers from the King Hamad Univeristy Hospital, Muharraq, Bahrain, have reported much lower rate of intensive care unit (ICU)...
FDA approves Tonix’ Phase 2 Trial of TNX-2900 for Prader-Willi SyndromeThe FDA has cleared Tonix Pharmaceuticals’ Investigational New Drug (IND) application to support clinical development of TNX-2900...
Roche poised to enter anti-obesity medication market with agreement to acquire Carmot TherapeuticsRoche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...
Pemvidutide achieves 15.6% weight loss at 48 weeksTopline results from the MOMENTUM Phase 2 obesity trial of pemvidutide has shown at week 48, subjects receiving pemvidutide achieved mean...
Night shift workers need support to manage weight and metabolic health Work based policies must be designed to target barriers that night shift workers face when managing weight and metabolic health...
Clearmind Medicine’s obesity drug shows positive results in a pre-clinical trialClearmind Medicine, a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major...
Pfizer’s twice-daily danuglipron formulation to be discontinued after high rates of GI complaintsTopline data from Pfizer’s Phase 2b clinical trial investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate,...
Living with overweight impedes the body's immune response to SARS-CoV-2Research led by University of Queensland has revealed that living with overweight can impair the body's antibody response to SARS-CoV-2...